Documents
Application Sponsors
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | TABLET;ORAL | 20MG | 2 | XOFLUZA | BALOXAVIR MARBOXIL |
002 | TABLET;ORAL | 40MG | 2 | XOFLUZA | BALOXAVIR MARBOXIL |
003 | SUSPENSION;ORAL | 40MG/20ML | 2 | XOFLUZA | BALOXAVIR MARBOXIL |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2020-11-23 | STANDARD |
EFFICACY; Efficacy | ORIG | 2 | AP | 2022-08-11 | STANDARD |
Submissions Property Types
CDER Filings
GENENTECH INC
cder:Array
(
[0] => Array
(
[ApplNo] => 214410
[companyName] => GENENTECH INC
[docInserts] => ["",""]
[products] => [{"drugName":"XOFLUZA","activeIngredients":"BALOXAVIR MARBOXIL","strength":"20MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"},{"drugName":"XOFLUZA","activeIngredients":"BALOXAVIR MARBOXIL","strength":"40MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"},{"drugName":"XOFLUZA","activeIngredients":"BALOXAVIR MARBOXIL","strength":"40MG\/20ML","dosageForm":"SUSPENSION;ORAL","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"}]
[labels] => [{"actionDate":"11\/23\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/214410s000,210854s004s010lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"11\/23\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/214410s000,210854s004s010lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2020-11-23
)
)